Lifecore Biomedical Inc (LFCR)
6.88
+0.22
(+3.30%)
USD |
NASDAQ |
May 07, 16:00
6.88
0.00 (0.00%)
After-Hours: 18:22
Lifecore Biomedical Cash from Financing (TTM): 56.06M for May 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
May 31, 2023 | 39.70M |
February 28, 2023 | 34.27M |
November 30, 2022 | -15.24M |
August 31, 2022 | -14.17M |
May 31, 2022 | -57.02M |
February 28, 2022 | -69.18M |
November 30, 2021 | -10.49M |
August 31, 2021 | -25.34M |
May 31, 2021 | -3.419M |
February 28, 2021 | 4.615M |
November 30, 2020 | -13.05M |
August 31, 2020 | 6.978M |
May 31, 2020 | 40.02M |
February 29, 2020 | 30.21M |
November 30, 2019 | 97.89M |
August 31, 2019 | 84.32M |
May 31, 2019 | 79.03M |
February 28, 2019 | 82.42M |
November 30, 2018 | 21.42M |
August 31, 2018 | 17.81M |
May 31, 2018 | 13.29M |
February 28, 2018 | 6.813M |
November 30, 2017 | 3.417M |
August 31, 2017 | 3.013M |
May 31, 2017 | -8.801M |
Date | Value |
---|---|
February 28, 2017 | -10.04M |
November 30, 2016 | 1.764M |
August 31, 2016 | 11.67M |
May 31, 2016 | 15.42M |
February 29, 2016 | 6.889M |
November 30, 2015 | 0.722M |
August 31, 2015 | 0.402M |
May 31, 2015 | 7.706M |
February 28, 2015 | 14.10M |
November 30, 2014 | 11.44M |
August 31, 2014 | 3.524M |
May 31, 2014 | -7.179M |
February 28, 2014 | -7.804M |
November 30, 2013 | -10.91M |
August 31, 2013 | -10.10M |
May 31, 2013 | -19.27M |
February 28, 2013 | 21.83M |
November 30, 2012 | 25.47M |
August 31, 2012 | 21.21M |
May 31, 2012 | 35.93M |
February 29, 2012 | -5.676M |
November 30, 2011 | -6.952M |
August 31, 2011 | -4.307M |
May 31, 2011 | -4.764M |
February 28, 2011 | 17.08M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-69.18M
Minimum
Feb 2022
97.89M
Maximum
Nov 2019
12.30M
Average
4.615M
Median
Feb 2021
Cash from Financing (TTM) Benchmarks
Aquestive Therapeutics Inc | 3.974M |
SELLAS Life Sciences Group Inc | 22.32M |
ADMA Biologics Inc | -38.99M |
Relmada Therapeutics Inc | -0.0985M |
Jaguar Health Inc | 34.23M |